Australian Clinical Labs prices IPO
Australian Clinical Labs will head to the market as a business with a market value of more than $800m.
Data Room
Four in Latitude’s corner for IPO
Four names have emerged as the cornerstone support for the float of the $2.7 billion non-bank lender Latitude Financial.
Hazeldene Chickens heads to market
The country’s third largest poultry producer, Hazeldene Chickens, has been placed on the market.
Goldman Sachs tapped for Perfection Fresh sale
The Smorgon family-backed fruit and vegetable grower Perfection Fresh is understood to have hired investment bank Goldman Sachs for a sale of the business.
Grow Finance launches IPO plans
Grow Finance is believed to be moving forward with plans for an initial public offering, hiring E&P Corporate Advisory to work on the float.
Deals to press reset on real estate sector
The latest spate of major corporate deals in real estate is expected to create a reweighting of the entire sector.
Dealmakers focus on clean energy sector
Dealmakers are reporting a diminishing appetite by major global funds embarking on M&A activity in areas related to sectors such as oil and gas.
$1.2bn tip for CBA insurance
Price expectations for CBA’s general insurance unit are rising, with some now expecting $1.2bn.
Victoria seeking adviser for VicRoads sale
The Victoria government is believed to be launching a beauty parade to find an adviser for the sale of its motor registry unit VicRoads.
Pepper Money roadshow tests IPO support
Pepper Money is believed to be launching a management roadshow this week for its initial public offering.
Float of chemical waste group DGL on track
Chemical waste management business DGL Group is believed to be working towards locking in support for its $100m initial public offering.
Trajan Scientific looks to IPO
The IPO plans of Trajan Scientific and Medical are believed to be progressing, with meetings scheduled for prospective investors.
Clinical Labs valuation hits $1.67bn
Crescent Capital is believed to be asking investors to pay between eight and 10 times earnings for the float of its Australian Clinical Labs business.
AGL, Future Fund sweeten Tilt $2.8bn bid
The higher bid, which all but secures the sale of the energy play, comes on the heels of a Canadian pension fund approaching the board of Tilt Renewables with an offer of $NZ8 per share.
Waislitz buys 20% of skincare innovation start up
The billionaire chairman of Thorney Investments is taking a punt on a skincare innovation company.
Australian Clinical Labs ‘worth up to $1.67bn’
Analysts have estimated the value of Crescent Capital’s pathology business, ahead of an initial public offering.
Boral mulls cashing in on fly ash demand
Boral’s move to consider a sale of its US-based fly ash business comes at a time of strong demand for the material.
Citi to exit retail banking in Australia
Global banking major Citi is expected to confirm a well-flagged retreat from consumer banking in Australia when it releases its quarterly results in New York later Thursday.
Crescent Capital’s healthcare float to be close to $1bn
Crescent Capital is understood to be looking at piling in a double for its listing.
National Storage REIT could be good buy: analysts
Analysts suggest National Storage REIT could appeal to a suitor, as self-storage owners in Australia trade at discounts to global counterparts.
Original URL: https://www.theaustralian.com.au/business/dataroom/page/191